AMNEAL PHARMACEUTICALS, INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $64.47 million as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2022-03-01
- 2021-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $64.47M.
- 2020-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $68.22M; Finance Lease, Right-of-Use Asset, after Accumulated Amortization as first filed $58.68M.
- 2019-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $61.28M.
- 2019-01-01: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $64.00M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | Finance Lease, Right-of-Use Asset, after Accumulated Amortization as first filed |
|---|---|---|
| 2021-12-31 | $64.47M 10-K · filed 2022-03-01 | |
| 2020-12-31 | $68.22M 10-K · filed 2022-03-01 | $58.68M 10-K · filed 2021-03-01 |
| 2019-12-31 | $61.28M 10-K · filed 2021-03-01 | |
| 2019-01-01 | $64.00M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |